1. Medtech Insight
  2. >>Business
  3. >>R&D
  4. >>Clinical Trials

Brain Trust Advises US FDA On Aneurysm Device Trials

To help figure out how intracranial aneurysm devices should be evaluated in clinical trials, US FDA brought together its Neurological Devices Advisory Panel. The experts answered questions ranging from safety and efficacy endpoints that should be taken into consideration to post-market study requirements.

Brain

US FDA convened a panel of experts March 1 to help it figure out how to review intracranial aneurysm devices. The panel recommended several endpoints device-makers should consider when trying to determine if devices are safe and effective in clinical trials.

The agency's Neurological Devices Panel heard from FDA, industry, clinicians and patients at the meeting in Gaithersburg, Md., on what...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Clinical Trials

German Health Researchers Prep for Possible Disruptions to PubMed, ClinicalTrials.gov

IQWiG, Germany’s health technology assessment body, is making contingency plans in case key US resources it relies on for information retrieval, when conducting benefit assessments of new medicines, become unavailable.

Hip Resurfacing For Women: Embody Orthopaedic Awarded CE Mark For H1 Implant

 
• By Natasha Barrow

The ceramic device, designed to reduce complications, will be exclusively distributed by Zimmer Biomet and initially available in 30 hospitals, with broader European access expected by 2026.

Even ‘Small’ Leaks After Left Atrial Appendage Occlusion Raises Stroke Risk, Study Finds

 
• By Brian Bossetta

A Japanese study of Watchman LAA closure devices found that leaks of any size after implantation raise the risk of stroke. The study comes shortly after the US FDA issued an early alert for the Watchman access systems.

UK’s Dementia Trials Accelerator Works To Fast-Track Recruitment

 
• By Anabel Costa-Ferreira

A government-backed program is working on improving the ability to run dementia clinical trials in the UK, and access to trials for participants.

More from R&D